Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The linear no-threshold dose-effect relation: Is it relevant to radiation protection regulation?
1.H. J. Geiger, D. Rush, D. Michaels, D. B. Baker, J. Cobb, E. Fischer, A. Goldstein, H. S. Kahn, J. L. Kirsch, P. J. Landrigan, E. Mauss, and D. E. McLean, Dead Reckoning: A Critical Review of the Department of Energy’s Epidemiological Research (Physicians for Social Responsibility, Washington, D.C., 1992).
2.K. L. Mossman, “The linear no-threshold debate,” Med. Phys. 25, 279–284 (1998).
3.F. Hutchison, “Formation of two double-strand breaks in the same DNA molecule by a single high-energy photon of ionizing radiation,” Int. J. Radiat. Biol. 70, 505–512 (1996).
4.J. W. Gofman, Radiation-Induced Cancer from Low-Dose Exposure: An Independent Analysis (Committee for Nuclear Responsibility, Inc., San Francisco, CA, 1990), Chap. 19ff.
5.E. G. Knox, A. M. Stewart, G. W. Kneale, and E. A. Gilman, “Prenatal irradiation and childhood cancer,” J. Radiol. Prot. 7, 3–15 (1987).
6.E. G. Knox, A. M. Stewart, E. A. Gilman, and G. W. Kneale, “Background radiation and childhood cancer,” J. Radiol. Prot. 8, 9–18 (1988).
7.C. R. Muirhead and G. W. Kneale, “Prenatal irradiation and childhood cancer,” J. Soc. Radiol. Prot. 9, 209–212 (1989).
8.R. Edwards, “Radiation roulette,” New Sci. 156(2103), 37–40 (1997).
9.BEIR V, Committee on the Biological Effects of Ionizing Radiation, National Research Council. Health Effects of Exposure to Low Levels of Ionizing Radiation (National Academy Press, Washington, D.C., 1990), p. 22.
10.R. H. Nussbaum, W. Kohnlein, and R. E. Belsey, “Die neueste Krebsstatistik der Hiroshima-Nagasaki-Uberlebenden: Erhohtes Strahlenrisiko bei Dosen unterhalb 50 cGy (rad), Konsequenzen fur den Strahlenschutz,” Med. Klin. 86, 99–108 (1991).
11.W. Kohnlein and R. H. Nussbaum, “Reassessment of radiogenic cancer risk and mutagenesis at low doses of ionizing radiation,” Adv. Mutagen. Res. 3, 53–80 (1991).
12.D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth, and K. Mabuchi, “Studies of mortality of atomic bomb survivors. Report 12, Part 1, Cancer: 1950–1990,” Radiat. Res. 146, 1–27 (1996).
13.D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, S. Izumi, H. Dohy, and D. L. Preston, “Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958–1987,” Radiat. Res. 137 (Supp.), S17–S67 (1994).
14.A. M. Stewart and G. W. Kneale, “A-bomb radiation and evidence of late effects other than cancer,” Health Phys. 58, 729–735 (1990).
15.A. M. Stewart and G. W. Kneale, “A-bomb survivors: Further evidence of late effects of early deaths,” Health Phys. 64, 467–472 (1993).
16.D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy, T. Matsuo, H. Nonaka, D. R. Thompson, M. Soda, and K. Mabuchi, “Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950–1987,” Radiat. Res. 137 (Supp.), S68–S97 (1994).
17.R. A. Kleinerman, L. G. Littlefield, R. E. Tarone, A. M. Sayer, D. L. Cookfair, J. Wactawski-Wende, P. D. Inskip, A. W. Block, K. H. Ramesh, and J. D. Boice , Jr., “Chromosome aberrations in lymphocytes from women irradiated for benign and malignant gynecological disease,” Radiat. Res. 13, 40–46 (1994).
18.P. Oftedal, “Biological low-dose radiation effects,” Mutat. Res. 258, 191–205 (1991).
19.E. A. Gilman, G. W. Kneale, E. G. Knox, and A. M. Stewart, “Pregnancy x-rays and childhood cancers: effects of exposure age and radiation dose,” J. Radiol. Prot. 8, 3–8 (1988).
20.V. Beral, P. Fraser, L. Carpenter, M. Booth, A. Brown, and G. Rose, “Mortality of employees of the atomic weapons establishment, 1951–1982,” Br. Med. J. 297, 757–770 (1988).
21.G. W. Kneale and A. M. Stewart, “Re-analysis of Hanford data: 1944–1986 deaths,” Am. J. Ind. Med. 23, 371–389 (1993).
22.S. Wing, C. M. Shy, J. L. Wood, S. Wolf, D. L. Cragle, and E. L. Frome, “Mortality among workers at Oak Ridge National Laboratory: Evidence of radiation effects in follow-up through 1984,” JAMA 265, 1397–1402 (1991).
23.S. Wing, C. M. Shy, J. L. Wood, S. Wolf, D. L. Cragle, and E. L. Frome, “Correspondence,” JAMA 266, 652–654 (1991);
23.S. Wing, C. M. Shy, J. L. Wood, S. Wolf, D. L. Cragle, and E. L. Frome, JAMA 267, 929–930 (1991);
23.S. Wing, C. M. Shy, J. L. Wood, S. Wolf, D. L. Cragle, and E. L. Frome, Health Phys. 62, 260–264 (1992).
24.K. L. Mossman, M. Goldman, F. Masse, W. A. Mills, K. J. Schiager, and R. J. Vetter, “Health Physics Society Position Statement Radiation Risk in Perspective,” Health Phys. Soc. Newsletter XXIV (3), March (1996).
25.U.S. Department of Energy, Closing the Circle on the Splitting of the Atom (Office of Environmental Management, USDOE, January, 1995), p. 39.
26.Reference 9, p. 383.
27.Consequences of the Chernobyl Catastrophe: Human Health, edited by E. B. Burlakova (Center for Russian Environmental Policy, Scientific Council on Radiobiology Russian Academy of Sciences, Moscow, 1996).
28.C. Busby, Wings of Death (Green Audit Books Ltd., Aberystwyth, 1994).
29.J. A. Strand, M. P. Fujihara, T. M. Poston, and C. S. Abernethy, “Permanence of suppression of the primary immune response in rainbow trout, Salmo gairdneri, sublethally exposed to tritiated water during embryogenesis,” Radiat. Res. 91, 533–541 (1982).
30.C. Rooney, V. Beral, N. Maconochie, P. Fraser, and G. Davies, “Case-control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority,” Br. Med. J. 307, 1391–1397 (1993).
31.W. D. Atkinson, M. Marshall, and B. O. Wade, “Cancer risk has no effect on mortality,” Br. Med. J. 308, 268–269 (1994).
32.C. Robinette, S. Jablon, and T. Preston, Mortality of Nuclear Weapons Test Participants (National Research Council, National Academy Press, Washington, D.C., June 1985).
33.International Atomic Energy Agency (IAEA), The international Chernobyl project: an overview, Vienna, Austria (1991);
33.Also: IAEA’s International Chernobyl project outcome corroborates earlier findings. RERF Update 3, 1–2 (1991).
34.A. B. Hill, “The environment and disease: Association or causation?” Proc. R. Soc. Med.58, 295–300 (1965).
35.W. J. Schull, H. Nishitani, K. Hasuo, T. Kobayashi, I. Goto, and M. Otake, “Brain abnormalities among the mentally retarded prenatally exposed atomic bomb survivors,” RERF Technical Report (TR 13-91). Hiroshima: Radiation Effects Research Foundation (1991) and RERF Update 3, 3–4 (1991).
36.J. F. Bithell and C. A. Stiller, “A new calculation of the radiogenic risk of obstetric x-raying,” Stat. Med. 7, 857–864 (1988).
37.B. Modan, E. Alfandary, A. Chetrit, and L. Katz, “Increased risk of breast cancer after low-dose irradiation,” Lancet 8639, 629–631 (1989).
38.E. Ron and B. Modan, “Benign and malignant thyroid neoplasms in children irradiated for fungal scalp infection (tinea capitis),” J. Natl. Cancer Inst. 65, 7–11 (1980).
39.G. S. Wilkinson and N. A. Dreyer, “Leukemia among nuclear workers with protracted exposure to low-dose ionizing radiation,” Epidemiology 2, 305–309 (1991).
40.K. Messing, J. Ferrais, W. E. C. Bradley, J. Swartz, and A. M. Seifert, “Mutant frequency of radiotherapy technicians appears to be associated with recent dose of ionizing radiation,” Health Phys. 57, 537–544 (1989).
41.United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR 1988), Sources, Effects and Risks of Ionizing Radiation (United Nations, New York, 1988).
42.M. Ulstein, T. S. Jensen, L. M. Irgens, R. T. Lie, E. Sivertsen, and F. E. Skjeldestad, “Outcome of pregnancies in some counties in Norway prior and subsequent to the Chernobyl accident,” Tidsskr. Nor. Laegeforen 110, 359–362 (1990).
43.T. Harjulehto, T. Aro, T. Rytomaa, and L. Saxen, “The accident at Chernobyl and outcome of pregnancy in Finland,” Br. Med. J. 298, 995–997 (1989).
44.E. Czeizel and B. Billege, “Teratological evaluation of Hungarian pregnancy outcomes after the accident in the nuclear power station of Chernobyl,” Orvosi Hetilap 129, 457–462 (1988), in Hungarian.
45.J. Bound, B. Francis, and P. Harvey, “Down’s syndrome: Prevalence and ionising radiation in an area of north west England,” J. Epidemiol. Community Health 49, 164–170 (1995).
46.K. Sperling, S. Barnitzke, H. Edlinger, M. Geisler, H. D. Hager, K. R. Heldet al., “Gemeinschaftsstudie zur saisonalen und regionalen Haufigkeit pranatal diagnostizierter Chromosomenanomalien fur die Bundesrepublik Deutschland einschliesslich Berlin Im Jahre 1986,” Ann. Universitatis Saraviensis Med. 7 (Suppl.), 307–313 (1987).
47.K. Sperling, J. Pelz, R. D. Wegener, I. Schulzke, and E. Struck, “Frequency of Trisomy-21 in Germany before and after the Chernobyl accident,” Biomed. Pharmacother. 45, 255–262 (1991).
48.K. Sperling, J. Pelz, R. D. Wegener, A. Dorries, A. Gruters, and M. Mikkelsen, “Significant increase in Trisomy-21 in Berlin nine months after the Chernobyl reactor accident: Temporal or causal relation?” Br. Med. J. 309, 158–162 (1994).
49.K. Sperling, J. Pelz, R. D. Wegener, A. Dorries, A. Gruters, and M. Mikkelsen, “Bewertung eines Trisomie-21 Clusters,” Med. Genetik 6, 378–385 (1994).
50.K. F. Von Muhlendahl and K. Muck, “Chernobyl, low-dose radiation, and trisomy 21: Possibly something to worry about,” Eur. J. Pediatr. (1996).
51.C. N. Ramsay, P. M. Ellis, and H. Zealley, “Down’s syndrome in the Lothian region of Scotland 1978 to 1989,” Biomed. Pharmacother. 45, 267–272 (1991).
52.R. K. Whyte, “First day neonatal mortality since 1935: Re-examination of the Cross hypothesis,” Br. Med. J. 304, 343–346 (1992).
53.G. Luning, M. Schmidt, J. Scheer, and H. Ziggel, “Early Infant mortality in West Germany before and after Chernobyl,” Lancet 8671 1081–1083 (1989);
53.G. Luning, M. Schmidt, J. Scheer, and H. Ziggel, Lancet 8682 161–162 (1990).
54.J. Scheer, “Early infant mortality in West Germany before and after Chernobyl,” Br. Med. J. 304, 843 (1992).
55.S. Bose and E. H. Kruger, “Auswirkungen des Tschernobylunfalles auf die Sauglingssterblichkeit, auch in Suddeutschland,” Kind and Umwelt II, edited by S. Bose and E. H. Kruger (Mabuse-Verlag, Munchen, 1993), 129–147.
56.A. Korblen and H. Kuchenhoff, “Perinatal mortality in Germany following the Chernobyl accident,” Radiat. Environ. Biophys. 36, 3–7 (1997).
57.G. Haaf, G. Kaatsch, J. Kreis, J. Michaelis, and F. Berthold, Fall-Kontroll-Studie zum Anstieg der Neuroblastominzidenz fur im Jahr 1988 geborene Kinder. Europaische Perspekitiven der medizinischen. Informatik, Biometrie und Epidemiologie, edited by J. Michaelis (MMV Verlag, Munchen, 1993), pp. 28–32.
58.J. J. Mangano, “Chernobyl and Hypothyrodism,” Lancet 347, 1482–1483 (1996);
58.J. J. Mangano, Lancet 348, 476–477 (1996).
59.J. J. Reid and J. J. Mangano, “Thyroid Cancer in the United States since the accident in Chernobyl,” Br. Med. J. 311, 511 (1995).
60.J. J. Mangano, “A post-Chernobyl rise in thyroid cancer in Connecticut, USA,” Eur. J. Cancer Prev. 5, 75–81 (1996).
61.E. Petridou, D. Trichopoulos, N. Dessypris, V. Flytzani, S. Haidas, M. Kalmanti, D. Kolliouskas, H. Kosmidis, F. Piperopoulou, and F. Tzortzatou, “Infant leukemia after in utero exposure to radiation from Chernobyl,” Nature (London) 382, 352-353 (1996);
61.E. Petridou, D. Trichopoulos, N. Dessypris, V. Flytzani, S. Haidas, M. Kalmanti, D. Kolliouskas, H. Kosmidis, F. Piperopoulou, and F. Tzortzatou, Nature (London) 387, 246 (1997).
62.J. Michaelis, U. Kaletsch, W. Burkart, B. Grosche, E. Petridou, D. Trichopoulos et al., Nature (London) 387, 246 (1997).
63.J. J. Mangano, “Childhood leukaemia in US may have risen due to fallout from Chernobyl,” Br. Med. J. 314, 1200 (1997).
64.V. E. Archer, “Association of nuclear fallout with leukemia in the United States,” Arch. Environ. Health 42, 263–271 (1987).
65.Y. E. Dubrova, V. N. Nesterov, N. G. Krouchinsky, V. A. Ostapenko, R. Neumann, D. L. Neil, and A. J. Jeffreys, “Human minisatellite mutation rate after the Chernobyl accident,” Nature (London) 380, 683–686 (1996).
66.R. J. Baker, R. A. Van Den Bussche, A. J. Wright, L. E. Wiggins, M. J. Hamilton, E. P. Reat, M. H. Smith, M. D. Lomakin, and R. K. Chesser, “High levels of genetic change in rodents of Chernobyl,” Nature (London) 380, 707–708 (1996).
67.A. Hilson, “Prostatic cancer and radionuclides,” Br. Med. J. 308, 268 (1994).
68.C. Busby, “Excess of other cancers in Wales,” Br. Med. J. 308, 268 (1994).
Article metrics loading...